UL Solutions Inc.

ULS ·Healthcare, Diagnostics & Research, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023
Revenue $730.0M $670.0M $684.0M $676.0M $689.0M $629.0M
Cost of Revenue $364.0M $351.0M $363.0M $344.0M $352.0M $335.0M
Gross Profit $366.0M $319.0M $321.0M $332.0M $337.0M $294.0M
Gross Margin 50.1% 47.6% 46.9% 49.1% 48.9% 46.7%
Operating Expenses
Research & Development — — — — — —
SG&A Expense $240.0M $228.0M $230.0M $206.0M $220.0M $219.0M
Operating Income $126.0M $91.0M $87.0M $89.0M $117.0M $75.0M
Operating Margin 17.3% 13.6% 12.7% 13.2% 17.0% 11.9%
Interest Expense — — — — — —
Pretax Income $134.0M $73.0M $79.0M $75.0M $120.0M $72.0M
Income Tax Expense $28.0M $13.0M $17.0M $18.0M $21.0M $14.0M
Net Income $101.0M $56.0M $58.0M $53.0M $94.0M $55.0M
Net Margin 13.8% 8.4% 8.5% 7.8% 13.6% 8.7%
EPS (Basic) $0.51 $0.28 $0.28 $0.27 $0.47 $0.28
EPS (Diluted) $0.50 $0.28 $0.28 $0.27 $0.47 $0.28
Shares Outstanding (Basic) 200.0M 200.0M 200.0M 200.0M 200.0M 200.0M
Shares Outstanding (Diluted) 201.0M 200.0M 200.0M 200.0M 200.0M 200.0M
Dividends Per Share $0.13 $0.13 $3.10 $0.10 $0.10 $0.10
← Newer Page 2 of 2 Older →